Isolated, tyrosinase derived peptides and uses thereof
AssigneeLudwig Institute for Cancer Research
InventorsThomas Wolfel, Aline Van Pel, Vincent Brichard, Thierry Boon-Falleur
Life of this patent
Estimating the term…
Abstract
The invention relates to the identification of complexes of human leukocyte antigen molecules and tyrosinase derived peptides on the surfaces of abnormal cells. The therapeutic and diagnostic ramifications of this observation are the subject of the invention.
Claims7
A method for identifying a subject for treatment with a therapeutic agent which is specific for complexes of an MHC molecule and a tyrosinase derived peptide selected from the group consisting of SEQ ID NO:
- 7, and SEQ ID NO:
- 8, wherein said complexes are present on surfaces of abnormal cells of said subject, comprising:
- (i) contacting a sample containing abnormal cell, which has been taken from said subject, with a cytolytic T cell specific for said complexes, and
- (ii) determining lysis of at least some of said abnormal cells as an indication that the subject is a candidate for said treatment.
Isolated cytolytic T cell specific for a complex of an MHC molecule selected from the group consisting of HLA-B44 and a tyrosinase derived peptide selected from the group consisting of SEQ ID NO:
- 7, and SEQ ID NO:
- 8.
A method for identifying abnormal cells which present complexes of an MHC molecule and a tyrosinase derived peptide selected from the group consisting of SEQ ID NO:
- 7 and SEQ ID NO;
- 8 on their surfaces, comprising contacting a sample which contains said abnormal cells with a cytolytic T cell specific for said complexes, and determining lysis of said abnormal cells by said cytolytic T cells as a determination of said abnormal cells.
Dependencies are inferred from the claim text.